•Opus Genetics releases positive phase 1/2 data in BEST1 retinal disease•Kala Bio and Virotek partner on US ophthalmic genetic testing•Diabetes raises ulcerative keratitis risk by 60%, study finds•Surrozen submits IND to FDA for DME therapeutic •GMAC names 2026-2027 international advisory panel •Opus Genetics releases positive phase 1/2 data in BEST1 retinal disease•Kala Bio and Virotek partner on US ophthalmic genetic testing•Diabetes raises ulcerative keratitis risk by 60%, study finds•Surrozen submits IND to FDA for DME therapeutic •GMAC names 2026-2027 international advisory panel
HEADLINES
FEATURED
Company emerges from stealth with $12 million in financing and a sneak peek of the Legato Frames, designed with patented hearing-assistance tech.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
